Maternal age at first cesarean delivery related to adverse pregnancy outcomes in a second cesarean delivery: a multicenter, historical, cross-sectional cohort study
To determine the effects of maternal age at first cesarean on maternal complications and adverse outcomes of pregnancy with the second cesarean.
Methods
This was a multicenter, historical, cross-sectional cohort study involving singleton pregnancies ≥28 gestational weeks, with a history of 1 cesarean delivery, and who underwent a second cesarean between January and December 2017 at 11 public tertiary hospitals in 7 provinces of China. We analyzed the effects of maternal age at first cesarean on adverse outcomes of pregnancy in the second cesarean using multivariate logistic regression analysis.
Results
The study consisted of 10,206 singleton pregnancies. Women were at first cesarean between 18 and 24, 25–29, 30–34, and ≥ 35 years of age; and numbered 2711, 5524, 1751, and 220 cases, respectively. Maternal age between 18 and 24 years at first cesarean increased the risk of placenta accreta spectrum (aOR, 1.499; 95% CI, 1.12–2.01), placenta previa (aOR, 1.349; 95% CI, 1.07–1.70), intrahepatic cholestasis of pregnancy (aOR, 1.947; 95% CI, 1.24–3.07), postpartum hemorrhage (aOR, 1.505; 95% CI, 1.05–2.16), and blood transfusion (aOR, 1.517; 95% CI, 1.21–1.91) in the second cesarean compared with the reference group (aged 25–29 years). In addition, maternal age ≥ 35 years at first cesarean was a risk factor for premature rupture of membranes (aOR, 1.556; 95% CI, 1.08–2.24), placental abruption (aOR, 6.464, 95% CI, 1.33–31.51), uterine rupture (aOR, 7.952; 95% CI, 1.43–44.10), puerperal infection (aOR, 6.864; 95% CI, 1.95–24.22), neonatal mild asphyxia (aOR, 4.339; 95% CI, 1.53–12.32), severe asphyxia (aOR, 18.439; 95% CI, 1.54–220.95), and admission to a neonatal intensive care unit (aOR, 2.825; 95% CI, 1.54–5.17) compared with the reference group (aged 25–29 years).
Conclusions
Maternal age between 18 and 24 years or advanced maternal age at first cesarean was an independent risk factor for adverse maternal outcomes with the second cesarean. Advanced maternal age at the first cesarean specifically increased adverse neonatal outcomes with the second. Therefore, decisions as to whether to perform a first cesarean at a young or advanced maternal age must be critically evaluated.
Shilei Bi and Lizi Zhang contributed equally to this work.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BMI
Body mass index
CD
Cesarean delivery
aOR
Adjusted odds ratios
CI
Confidence interval
PAS
Placenta accreta spectrum
PP
Placenta previa
ICP
Intrahepatic cholestasis of pregnancy
PPH
Postpartum hemorrhage
PROM
Premature rupture of membrane
NICU
Neonatal intensive care unit
AMA
Advanced maternal age
ITP
Idiopathic thrombocytopenic purpura
DM
Diabetes mellitus
DIC
Disseminated intravascular coagulation
FGR
Fetal growth restriction
Background
Age plays a significant role in infertility, pregnancy-related complications, and adverse obstetric and perinatal outcomes [1]. As the average human life span increases [2], the role of age in the development and outcome of diseases [2, 3] has also changed concomitantly. An apparent trend in obstetrics worldwide is that childbearing is being postponed to later age [4, 5]. Although advanced maternal age (AMA) is currently defined as maternal age 35 years or older at the time of delivery [6], some investigators define AMA as over 40 years [7, 8]. This trend is partially attributed to women’s pursuit of higher education, desire to have successful careers, and wish to attain financial stability [7, 9]. In addition, women delay childbearing by modifications to lifestyle (delayed marriage and increased rates of divorce) or due to underlying subfertility [10]. Effective contraception, developments in assisted reproductive technology, and multiparous women have also driven a shift toward postponing motherhood or bearing an additional child at a more advanced age [11]. The risks to women and newborns associated with AMA have therefore recently undergone greater scrutiny.
The rate of cesarean delivery (CD) has risen rapidly worldwide in recent years. In China, the cesarean rate increased from 28.8% in 2008 to 34.9% in 2014 [12], considerably above the World Health Organization (WHO)-recommended rate of 10–15% of total births [13]. It also appears that AMA is occurring concomitantly with the increasing rate in cesarean delivery. A systematic review with meta-analysis has demonstrated that AMA increased the risk of obstetric interventions such as CD [14]. Due to the previous “one-child” family planning policy in China, many women requested elective CD without valid medical indications for fear of a long and painful labor, or unplanned cesarean delivery after failure of vaginal birth or pelvic floor trauma [15]. In 2016, the enactment of the 2-child policy was expected to increase the rate of CDs as related to previous cesarean history [16].
Anzeige
Many investigators have reported on the relationship between maternal age and obstetric complications and/or adverse outcomes in pregnancy [17, 18]. Additionally, some studies have indicated an association between short inter-pregnancy interval and poor birth outcomes in the succeeding pregnancy—including preterm birth and extremely low birth weight—in women with advanced age [19, 20]. Qin et al. reported that AMA and previous cesarean section were both risk factors for adverse outcomes of pregnancy during second pregnancies [21]. However, little is known regarding the effects of age at first delivery on the subsequent pregnancy, especially the age at the first CD. To garner more insight into possible links, we herein analyzed the association between maternal age at first CD and complications and adverse outcomes of pregnancy in the second CD using data from 11 public tertiary hospitals within 7 provinces of China.
Methods
Study design
This was a multicenter, historical, cross-sectional cohort study conducted at 11 public tertiary hospitals covering 7 provinces, municipalities, and autonomous regions within China (Guangdong, Beijing, Xinjiang, Shanxi, Henan, Hubei, and Chongqing). The cohort comprised 14,734 women with uterine scars who delivered again between January 2017 and December 2017. We selected women with singleton pregnancies at ≥28 gestational weeks, and with a CD history who underwent a repeat CD. Antepartum fetal death, major fetal congenital anomalies, a scarred uterus caused by myomectomy, and a history of 2 or more CDs were excluded. Women lacking their essential records—such as delivery mode or severe data loss—were also excluded. Figure 1 shows a flow diagram of the women’s enrollment process.
×
Research methods
Data were obtained by chart review based on electronic medical records. Maternal clinical characteristics included maternal ages at the first and second CDs, gestational weeks, gravidity, parity, nationality, mode of conception (natural vs. assisted), source of pregnant women (“referral” meant that pregnant women were referred from low-level hospitals to tertiary hospitals. “hospital” meant that pregnant women delivered in a tertiary hospital from the beginning), body mass index (BMI) before pregnancy, number of months (interval) between the 2 CDs, sex of the offspring, and indications for the 2 CDs.
We reviewed the electronic medical records with regard to complications, and the following details were recorded: premature rupture of membranes (PROM), placenta previa (PP), placenta accreta spectrum disorders (PAS), placental abruption, idiopathic thrombocytopenic purpura (ITP), abnormal amniotic fluid (oligohydramnios and polyhydramnios), hypertension disorders, diabetes mellitus (DM), thyroid diseases (hypothyroidism and hyperthyroidism), and intrahepatic cholestasis of pregnancy (ICP).
Anzeige
We collected adverse maternal outcomes, including any of the following: postpartum hemorrhage (PPH), severe PPH, uterine rupture, disseminated intravascular coagulation (DIC), puerperal infection, hysterectomy, bladder injury, and blood transfusion. We defined PPH as a loss of ≥1000 ml of blood after cesarean delivery and severe PPH as the loss of ≥1500 ml of blood after cesarean delivery.
Adverse neonatal outcomes included prematurity (< 37 weeks), fetal growth restriction (FGR), mild asphyxia (1-min Apgar score < 8), severe asphyxia (1-min Apgar score < 4), neonatal complication, and admission to a neonatal intensive care unit (NICU). FGR is an estimated fetal weight that is less than the 10th percentile for gestational age. Neonatal complication included neonatal asphyxia, neonatal malformation and other complications (hemolysis, jaundice, congenital heart disease, meconium aspiration pneumonia, et al.).
Information regarding maternal and neonatal diseases was classified according to the WHO’s Classification of diseases (ICD)-10.
Statistical analyses
We performed statistical analyses using SPSS v24.0 for Windows and R software (version 3.6.1). Missing values were imputed using a random forest algorithm. Missing data was listed in Supplementary Table S1. We examined whether quantitative data were normally distributed using the Kolmogorov-Smirnov test. Non-parametric continuous features are presented as medians and their corresponding interquartile ranges (IQR), and the Kruskal-Wallis test was applied for comparisons among multiple groups. Categorical variables are reported as frequencies (percentages), and the differences between groups were compared using the χ2 or Fisher exact-probability test in the case of small numbers, where appropriate. The associations between maternal age at first CD and each outcome were investigated by logistic regression analysis in 2 models: model 1 was adjusted for possible confounders—including gravidity, parity, BMI, assisted reproductive technology, and interval months; and with model 2 we explored possible explanations of the findings by adding mediating factors—i.e., maternal age at the second CD [19]. There is no official international definition of “advanced maternal age,” nor is there an “age interval” or reference group of maternal age [20]. According to most studies and guidelines, adolescent mothers have been excluded as a unique group. The rationale for our choice of a reference group (25–29 years) for this study was that the expected outcomes would be optimal for this age range, which also included the largest number of pregnancies. We also calculated crude odds ratios (ORs) and adjusted odds ratios (aORs), along with their 95% confidence intervals (CIs). Differences with P-values of < 0.05 were considered to be statistically significant.
Results
The present study consisted of 10,206 women with a history of CD who underwent a repeat CD. Women at their first CD were aged 18–24 years, 25–29 years, 30–34 years, and ≥ 35 years; and numbered 2711, 5524, 1751, and 220 cases, respectively. Figure 2 shows that the indications for the first CDs were principally pregnancy complications, fetal distress, failure of labor, abnormal fetal position, social factors, and unknown reasons. The indications for the second CDs were primarily uterine scarring, pregnancy complications, fetal distress, failure of labor, and abnormal fetal position. The compositional ratio of CD indications was similar for different age groups, and scarred uterus was the primary indication for a second CD.
×
Table 1 shows the general characteristics and potentially mediating factors for the women undergoing a consecutive CD—with the median values showing an increase, and the median interval between the 2 cesareans shortened in an almost continuously commensurate fashion relative to the age at first CD: 18–24 years of age (second CD at a median age of 29 years, with a median interval of 84 months); 25–29 years (33 years and 72 months); 30–34 years (36 years and 60 months); and ≥ 35 years (40 years and 48 months). In the group of women who were older than 35 years at their first CD, gravidity and parity increased; and more women underwent assisted reproductive technology prior to the second CD compared with other groups. A greater number of women between 18 and 24 years of age at their first CD tended to be either leaner (a BMI less than 18.5 kg/m2) or obese (a BMI above 30 kg/m2) with the second CD.
Table 1
General characteristics of women in various age ranges undergoing their second CD
Variables
18–24
(n = 2711)
25–29
(5524)
30–34
(n = 1751)
≥35
(220)
P
Gravidity
< 0.05
2
1212 (44.7%)
2804 (50.8%)
925 (52.8%)
79 (35.9%)
3
829 (30.6%)
1606 (29.1%)
477 (27.2%)
58 (26.4%)
≥ 4
670 (24.7%)
1114 (20.2%)
349 (19.9%)
83 (37.7%)
Parity
< 0.05
1
2626 (96.9%)
5397 (97.7%)
1663 (95%)
178 (80.9%)
2
73 (2.7%)
115 (2.1%)
77 (4.4%)
36 (16.4%)
≥ 3
12 (0.4%)
12 (0.2%)
11 (0.6%)
6 (2.7%)
Age at second CD
29 (27,33)
33 (31,36)
36 (35,38)
40 (38,42)
< 0.05
BMI (kg/m2)
< 0.05
< 18.5
266 (9.8%)
381 (6.9%)
88 (5%)
7 (3.2%)
18.5–24.9
1812 (66.8%)
3783 (68.5%)
1208 (69%)
153 (69.5%)
25–29.9
538 (19.8%)
1200 (21.7%)
394 (22.5%)
54 (24.5%)
≥30
95 (3.5%)
160 (2.9%)
61 (3.5%)
6 (2.7%)
Nationality
< 0.05
Han
2673 (98.6%)
5414 (98%)
1710 (97.7%)
208 (94.5%)
Others
38 (1.4%)
110 (2%)
41 (2.3%)
12 (5.5%)
Interval months
84 (53,120)
72 (48,108)
60 (40,84)
48 (32.25,60.75)
< 0.05
ART
72 (2.7%)
100 (1.8%)
71 (4.1%)
14 (6.4%)
< 0.05
Source
< 0.05
Hospital
2126 (78.4%)
4626 (83.7%)
1492 (85.2%)
185 (84.1%)
Referral
585 (21.6%)
898 (16.3%)
259 (14.8%)
35 (15.9%)
Gestational weeks
39 (37,39)
39 (38,39)
39 (38,39)
39 (37.25,39)
< 0.05
Sex
0.951
Male
1477 (54.5%)
3047 (55.2%)
960 (54.8%)
121 (55%)
Female
1234 (45.5%)
2477 (44.8%)
791 (45.2%)
99 (45%)
BMI Body mass index, ART Assisted reproductive technology, CD Cesarean delivery
The effects of maternal age at first CD on maternal complications with the second CD were the principal findings of our study (model 2). A maternal age of 18–24 years at the first CD increased the risk of PAS (aOR, 1.499; 95% CI, 1.12–2.01), PP (aOR, 1.349; 95% CI, 1.07–1.70), and ICP (aOR, 1.947; 95% CI, 1.24–3.07) at the second CD compared with the reference group (aged 25–29 years). By comparison, maternal age ≥ 35 years at first CD was a risk factor for PROM (aOR, 1.556; 95% CI, 1.08–2.24) and placental abruption (aOR, 6.464; 95% CI, 1.33–31.51) (Table 2).
Table 2
Maternal complications of a second CD for women of different age ranges at the first CD
Variables
Age
N (%)
OR (95%CI)
Model 1
Model 2
PAS
18–24
226 (8.3)
1.391 (1.17–1.66)
1.369 (1.15–1.63)
1.499 (1.12–2.01)
25–29
339 (6.1)
1
1
1
30–34
103 (5.9)
0.956 (0.76–1.20)
0.888 (0.70–1.12)
0.815 (0.59–1.12)
≥35
25 (11.4)
1.961 (1.28–3.02)
1.387 (0.88–2.18)
1.149 (0.59–2.24)
PP
18–25
390 (14.4)
1.322 (1.15–1.51)
1.335 (1.16–1.53)
1.349 (1.07–1.70)
25–29
623 (11.3)
1
1
1
30–34
193 (11)
0.975 (0.82–1.16)
0.879 (0.74–1.05)
0.87 (0.68–1.11)
≥35
36 (16.4)
1.539 (1.07–2.22)
1.063 (0.72–1.56)
1.04 (0.61–1.78)
Placental abruption
18–24
31 (1.1)
1.32 (0.84–2.08)
1.356 (0.86–2.14)
0.793 (0.37–1.69)
25–29
48 (0.9)
1
1
1
30–34
19 (1.1)
1.251 (0.73–2.14)
1.252 (0.73–2.16)
2.055 (0.95--4.44)
≥35
4 (1.8)
2.113 (0.76–5.91)
2.202 (0.76–6.38)
6.464 (1.33–31.51)
Abnormal amniotic fluid
18–24
299 (11)
1.075 (0.93–1.25)
1.108 (0.96–1.29)
0.974 (0.76–1.25)
25–29
571 (10.3)
1
1
1
30–34
165 (9.4)
0.902 (0.75–1.08)
0.823 (0.68–0.99)
0.932 (0.72–1.21)
≥35
20 (9.1)
0.867 (0.54–1.39)
0.73 (0.46–1.17)
0.971 (0.52–1.81)
Hypertension
18–24
296 (10.9)
1.08 (0.93–1.25)
1.093 (0.94–1.27)
1.044 (0.82–1.34)
25–29
563 (10.2)
1
1
1
30–34
190 (10.9)
1.073 (0.90–1.28)
1.022 (0.86–1.22)
1.076 (0.83–1.39)
≥35
32 (14.5)
1.5 (1.02–2.20)
1.297 (0.87–1.93)
1.456 (0.83–2.57)
DM
18–24
579 (21.4)
0.853 (0.76–0.95)
0.827 (0.74–0.93)
1.091 (0.91–1.31)
25–29
1334 (24.1)
1
1
1
30–34
485 (27.7)
1.203 (1.07–1.36)
1.275 (1.13–1.44)
0.976 (0.81–1.17)
≥35
72 (32.7)
1.528 (1.15–2.04)
1.63 (1.21–2.19)
0.907 (0.60–1.37)
PROM
18–24
333 (12.3)
0.915 (0.80–1.05)
0.918 (0.80–1.06)
0.905 (0.78–1.05)
25–29
733 (13.3)
1
1
1
30–34
238 (13.6)
1.028 (0.88–1.20)
1.013 (0.86–1.19)
1.022 (0.87–1.20)
≥35
42 (19.1)
1.542 (1.09–2.18)
1.529 (1.07–2.18)
1.556 (1.08–2.24)
ICP
18–24
37 (1.4)
1.946 (1.24–3.06)
1.927 (1.23–3.03)
1.947 (1.24–3.07)
25–29
39 (0.7)
1
1
1
30–34
11 (0.6)
0.889 (0.45–1.74)
0.897 (0.46–1.76)
0.892 (0.45–1.76)
≥35
2 (0.9)
1.29 (0.31–5.38)
1.317 (0.32–5.49)
1.321 (0.31–5.65)
ITP
18–24
55 (2)
1.465 (1.03–2.08)
1.565 (1.10–2.22)
1.057 (0.70–1.60)
25–29
77 (1.4)
1
1
1
30–34
15 (0.9)
0.611 (0.35–1.07)
0.528 (0.30–0.99)
0.779 (0.44–1.39)
≥35
1 (0.5)
0.323 (0.05–2.33)
0.246 (0.03–1.79)
0.58 (0.08–4.34)
Thyroid disease
18–24
69 (2.5)
0.651 (0.49–0.86)
0.632 (0.48–0.83)
1.031 (0.68–1.57)
25–29
213 (3.9)
1
1
1
30–34
88 (5)
1.319 (1.02–1.70)
1.406 (1.08–1.82)
0.907 (0.61–1.35)
≥35
12 (5.5)
1.439 (0.79–2.62)
1.605 (0.88–2.94)
0.633 (0.26–1.57)
PAS Placenta accreta spectrum disorders, PP Placenta previa, DM Diabetes mellitus, PROM Premature rupture of membranes, ICP Intrahepatic cholestasis of pregnancy, ITP Idiopathic thrombocytopenic purpura, OR Odds ratios, CI Confidence interval
Model 1: adjusted factors included gravidity, parity, BMI, ART, and interval months
Model 2: adjusted factors included gravidity, parity, BMI, ART, interval months, and maternal age at second CD
We further explored the effects of maternal age at first CD on adverse maternal and neonatal outcomes with the second CD (Tables 3 and 4). A maternal age of 18–24 years at the first CD increased the risk of PPH (aOR, 1.505; 95% CI, 1.05–2.16) and blood transfusion (aOR, 1.517; 95% CI, 1.21–1.91) with the second CD compared with the reference group (aged 25–29 years), while maternal age ≥ 35 years at first CD was a risk factor for uterine rupture (aOR, 7.952; 95% CI, 1.43–44.10) and puerperal infection (aOR, 6.864; 95% CI, 1.95–24.22).
Table 3
Adverse maternal outcomes for the second CD of women in different age ranges at first CD
Variables
Age
N (%)
OR (95%CI)
Model 1
Model 2
PPH
18–24
155 (5.7)
1.581 (1.28–1.96)
1.521 (1.23–1.89)
1.505 (1.05–2.16)
25–29
204 (3.7)
1
1
1
30–34
64 (3.7)
0.989 (0.74–1.32)
0.971 (0.73–1.29)
0.974 (0.65–1.46)
≥35
9 (4.1)
1.112 (0.56–2.20)
0.913 (0.46–1.82)
0.88 (0.35–2.23)
Severe PPH
18–24
79 (2.9)
1.45 (1.08–1.94)
1.383 (1.03–1.86)
1.188 (0.72–1.95)
25–29
112 (2)
1
1
1
30–34
28 (1.6)
0.785 (0.52–1.19)
0.729 (0.48–1.11)
0.858 (0.49–1.52)
≥35
4 (1.8)
0.895 (0.33–2.45)
0.552 (0.20–1.57)
0.793 (0.21–3.06)
Blood transfusion
18–24
182 (6.7)
1.76 (1.44–2.16)
1.745 (1.42–2.14)
1.517 (1.21–1.91)
25–29
217 (3.9)
1
1
1
30–34
60 (3.4)
0.868 (0.65–1.16)
0.816 (0.61–1.10)
0.926 (0.68–1.25)
≥35
10 (4.5)
1.165 (0.61–2.23)
0.853 (0.44–1.67)
1.127 (0.57–2.23)
DIC
18–24
3 (0.1)
3.059 (0.51–18.32)
2.987 (0.49–18.22)
1.501 (0.08–26.37)
25–29
2 (0)
1
1
1
30–34
0
0
0.806 (0.61–0.10)
0
≥35
1 (0.5)
12.607 (1.14–139.57)
13.95 (1.05–185.44)
51.8 (0.32–8409.68)
Uterine rupture
18–24
11 (0.4)
2.497 (1.03–6.03)
2.579 (1.06–6.25)
2.034 (0.75–5.49)
25–29
9 (0.2)
1
1
1
30–34
4 (0.2)
1.403 (0.43–4.56)
1.294 (0.39–4.27)
1.626 (0.48–5.53)
≥35
2 (0.9)
5.622 (1.21–26.18)
5.002 (1.01–24.73)
7.952 (1.43–44.10)
Hysterectomy
18–24
2 (0.1)
0.679 (0.14–3.37)
0.304 (0.06–1.69)
0.387 (0.03–4.50)
25–29
6 (0.1)
1
1
1
30–34
1 (0.1)
0.526 (0.06–4.37)
1.208 (0.13–10.90)
0.939 (0.05–16.67)
≥35
0
0
0.806 (0.61–0.10)
0
Bladder injury
18–24
43 (1.6)
1.111 (0.76–1.62)
1.03 (0.71–1.50)
1.199 (0.80–1.81)
25–29
79 (1.4)
1
1
1
30–34
31 (1.8)
1.242 (0.82–1.89)
1.3 (0.85–2.00)
1.128 (0.73–1.74)
≥35
3 (1.4)
0.953 (0.30–3.04)
0.904 (0.28–2.94)
0.661 (0.20–2.19)
Puerperal infection
18–24
10 (0.4)
0.97 (0.46–2.06)
0.986 (0.46–2.10)
0.737 (0.32–1.72)
25–29
21 (0.4)
1
1
1
30–34
4 (0.2)
0.6 (0.21–1.75)
0.585 (0.20–1.71)
0.68 (0.23–2.06)
≥35
4 (1.8)
4.853 (1.65–14.26)
4.634 (1.58–13.64)
6.864 (1.95–24.22)
PPH Postpartum hemorrhage, DIC Disseminated intravascular coagulation, OR Odds ratio, CI Confidence interval;
Model 1: adjusted factors included gravidity, parity, BMI, ART, and interval months
Model 2: adjusted factors included gravidity, parity, BMI, ART, interval months, and maternal age at second CD
Table 4
Neonatal outcomes of the second CD for woman of different age ranges at first CD
Variables
Age
N (%)
OR (95%CI)
Model 1
Model 2
FGR
18–24
72 (2.7)
2.037 (1.45–2.83)
2.061 (1.48–2.86)
1.223 (0.70–2.14)
25–29
73 (1.3)
1
1
1
30–34
24 (1.4)
1.038 (0.65–1.65)
1.025 (0.64–1.63)
1.641 (0.88–3.08)
≥35
1 (0.5)
0.341 (0.05–2.46)
0.332 (0.05–2.40)
0.857 (0.10–7.61)
Mild asphyxia
18–24
102 (3.8)
1.585 (1.22–2.06)
1.599 (1.23–2.08)
0.882 (0.57–1.38)
25–29
133 (2.4)
1
1
1
30–34
40 (2.3)
0.948 (0.66–1.36)
0.891 (0.62–1.28)
1.577 (0.97–2.57)
≥35
8 (3.6)
1.53 (0.74–3.16)
1.159 (0.55–2.46)
4.339 (1.53–12.32)
Severe asphyxia
18–24
10 (0.4)
1.019 (0.48–2.18)
1.014 (0.47–2.17)
0.317 (0.09–1.15)
25–29
20 (0.4)
1
1
1
30–34
2 (0.1)
0.315 (0.07–1.35)
0.292 (0.07–1.26)
0.831 (0.15–4.66)
≥35
2 (0.9)
2.525 (0.59–10.87)
1.776 (0.38–8.26)
18.439 (1.54–220.95)
Preterm
18–24
393 (14.5)
1.442 (1.26–1.66)
1.457 (1.27–1.67)
1.092 (0.87–1.38)
25–29
581 (10.5)
1
1
1
30–34
172 (9.8)
0.927 (0.78–1.11)
0.872 (0.73–1.05)
1.143 (0.89–1.47)
≥35
22 (10)
0.945 (0.60–1.48)
0.77 (0.49–1.22)
1.393 (0.77–2.53)
Neonatal complications
18–24
91 (3.4)
1.453 (1.11–1.91)
1.469 (1.12–1.93)
1.131 (0.72–1.79)
25–29
129 (2.3)
1
1
1
30–34
43 (2.5)
1.053 (0.74–1.49)
1.014 (0.71–1.44)
1.303 (0.80–2.13)
≥35
8 (3.6)
1.578 (0.76–3.27)
1.356 (0.65–2.85)
2.343 (0.82–6.74)
NICU
18–24
284 (10.5)
1.426 (1.22–1.67)
1.425 (1.22–1.67)
1.036 (0.79–1.35)
25–29
419 (7.6)
1
1
1
30–34
118 (6.7)
0.88 (0.71–1.09)
0.841 (0.68–1.04)
1.127 (0.84–1.51)
≥35
29 (13.2)
1.85 (1.24–2.77)
1.481 (0.98–2.25)
2.825 (1.54–5.17)
FGR Fetal growth restriction, NICU Neonatal intensive care unit, OR Odds ratio, CI Confidence interval;
Model 1: adjusted factors included gravidity, parity, BMI, ART, and interval months
Model 2: adjusted factors included gravidity, parity, BMI, ART, interval months, and maternal age at second CD
Anzeige
AMA at the first CD increased adverse neonatal outcomes with the second CD, including mild asphyxia (aOR, 4.339; 95% CI, 1.53–12.32), severe asphyxia (aOR, 18.439; 95% CI, 1.54–220.95), and admission to the NICU (aOR, 2.825; 95% CI, 1.54–5.17) compared with the reference group (aged 25–29 years).
After adjusting for maternal age at the second CD, maternal age ≥ 35 years at first CD did not influence the incidence of DIC (model 1: aOR, 13.951; 95% CI, 1.05–185.44; model 2: aOR, 51.8; 95% CI, 0.32–8409.68). In addition, the odds of ITP (model 1: aOR, 1.565; 95% CI, 1.10–2.22; model 2: aOR, 1.057; 95% CI, 0.70–1.60), severe PPH (model 1: aOR, 1.383; 95% CI, 1.03–1.86; model 2: aOR, 1.188; 95% CI, 0.72–1.95), uterine rupture (model 1: aOR, 2.579; 95% CI, 1.06–6.25; model 2: aOR, 2.034; 95% CI, 0.75–5.49), FGR (model 1: aOR, 2.061; 95% CI, 1.48–2.86; model 2: aOR, 1.223; 95% CI, 0.70–2.14), mild asphyxia (model 1: aOR, 0.87–1.38; model 2: aOR, 0.882, 95% CI, 0.57–1.38), neonatal complications (model 1: aOR, 1.469; 95% CI, 1.12–1.93; model 2: aOR, 1.131; 95% CI, 0.72–1.79), and admission to the NICU (model 1: aOR, 1.425; 95% CI, 1.22–1.67; model 2: aOR, 1.036; 95% CI, 0.79–1.35) for women between 18 and 24 years of age were not statistically significant with the second CD after adjusting for maternal age.
Discussion
We found that maternal age at the first cesarean delivery was associated with obstetric complications and adverse outcomes of pregnancy with the second cesarean delivery. Compared with the reference group (25–29 years), maternal age between 18 and 24 years at the first CD increased the risk of PAS, PP, ICP, PPH, and blood transfusion with the second CD. In addition, maternal age ≥ 35 years at first CD was a risk factor for PROM, placental abruption, uterine rupture, puerperal infection, mild neonatal asphyxia, severe asphyxia, and admission to the NICU. We found that ages between 25 and 34 years constituted optimal times for the first CD from the perspective of outcomes with the second CD. And the study can be used for counseling AMA or young patients about possible adverse outcome of a second CD.
We noted in our study that, intriguingly, maternal age between 18 and 24 years at first CD increased the risk of PAS, PP, ICP, PPH, and blood transfusion with the second CD. In the United States, the highest rate of unintended pregnancy occurs among young adult women in their early twenties (18–24 years). Young adult women are likely to be unmarried, poorer, cohabiting, or participating in the labor force without having completed a college education; and it has been reported that unintended pregnancies are associated with adverse infant and maternal health outcomes [21, 22]. Additionally, in young women, unhealthy behaviors such as tobacco use and high body mass index were independent risks for PAS and PP [23]; and postpartum endometritis due to ignorance of postpartum care and poor postpartum recovery was associated with PAS disorders in subsequent pregnancies [23]. PAS and PP were the principal reasons for PPH and blood transfusion with the second CD [24]. A history of illicit drug use and viral hepatitis of any type increased the risk of ICP, with the recurrence rates for ICP ranging from 40 to 92% [25].
Anzeige
In our study, maternal age ≥ 35 years at first CD was a substantial risk factor for PROM, placental abruption, uterine rupture, and puerperal infection. A large proportion of AMA pregnancies were undesirable and unplanned—with short interpregnancy intervals, insufficient recovery of the uterus, physiologic stresses of a previous pregnancy [26], and reduced resistance—all potentially related to adverse pregnancy outcomes. Furthermore, it was alarming that maternal age ≥ 35 years at first CD was associated with a 4-fold increase in neonatal mild asphyxia, 18-fold increase in severe asphyxia, and 2-fold increase in NICU admission. Numerous investigators have reported that AMA was a risk factor for preterm delivery [27], low birthweight [28], fetal chromosomal abnormalities [29], and fetal death [30]. AMA was also associated with pre-eclampsia, gestational diabetes, PROM, venous thromboembolism, and the use of assisted conception [17, 26]—which would likely increase adverse neonatal outcomes.
In China, the rate of CD increased from 28.8% in 2008 to 34.9% in 2014 [12]. When we analyzed the indications for the 2 CDs, we found that the compositional ratios of CD indications were similar for the different age groups. The primary indications for the first CDs were pregnancy complications and social factors, while for the second CDs they were scarred uterus and pregnancy complications. In order to reduce the rate of CD, vaginal birth after 1 CD without contraindications has been recommended in China. However, the proportion of trials of vaginal birth after 1 CS was lower (9.1%) in our previous study compared with that in other countries (75.6% in Israel [31] and 70% in France) [32]. In our study, the rate of trials of vaginal birth among women between 18 and 24 years of age at their first CD was higher than for women who were ≥ 35 years of age (14.9% vs. 4.5%, respectively). Our best advice is to avoid unnecessary CDs, encourage women to have their children at an appropriate age, and propose that more women choose a trial of labor after a CD so as to decrease excess risks. This paper can be used for counseling AMA or young patients about possible adverse outcome of a second CD.
Strengths and limitations
This study possesses several strengths. First, our study was based upon the multicenter database that encompassed 11 public tertiary hospitals; and it covered 7 provinces, municipalities, and autonomous regions within China in 2017, effectively avoiding the selection bias of single-center and small-sample studies. To some extent, these data can therefore be generalizable to more heterogeneous populations. Second, this was the first study of its kind on the effect of maternal age at first CD on the complications and adverse outcomes of the second CD. However, this study also has several limitations. This was a historical cohort study, and data from different centers were not always ideal and complete; some missing values were therefore imputed using the random forest algorithm. The number of women at their first CD with age ≥ 35 years was relatively small. Further repeated studies are needed.
Conclusions
In conclusion, this multicenter, historical, cross-sectional cohort study of singleton pregnancies showed that maternal age between 18 and 24 years at first CD increased the risks for PAS, PP, ICP, PPH, and blood transfusion with the second CD. Maternal age ≥ 35 years at first CD was a risk factor for PROM, placental abruption, uterine rupture, puerperal infection, neonatal mild asphyxia, severe asphyxia, and admission to a NICU. The underlying mechanism(s) governing these relationships are unclear, and therefore further studies are needed to confirm that both young and advanced maternal ages at first CD are risk factors for many serious complications and adverse pregnancy outcomes at the subsequent CD.
Anzeige
Acknowledgements
We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.
Ethics approval and consent to participate
This historical, cross-sectional cohort study was approved by the Medical Ethics Committee of Guangzhou Medical University with Medical Research No. 2016 (0406); the date of approval was April 6, 2016. All of the methods were performed in accordance with the relevant guidelines and regulations, and the statements on consent for participation were signed by participants and their legally authorized representatives.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no conflict of interest.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Maternal age at first cesarean delivery related to adverse pregnancy outcomes in a second cesarean delivery: a multicenter, historical, cross-sectional cohort study
verfasst von
Shilei Bi Lizi Zhang Jingsi Chen Minshan Huang Lijun Huang Shanshan Zeng Yulian Li Yingyu Liang Jinping Jia Suiwen Wen Yinli Cao Shaoshuai Wang Xiaoyan Xu Ling Feng Xianlan Zhao Yangyu Zhao Qiying Zhu Hongbo Qi Lanzhen Zhang Hongtian Li Zhijian Wang Lili Du Dunjin Chen
Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.
Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.
Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.
Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.
Update Gynäkologie
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.